99 related articles for article (PubMed ID: 8561075)
1. Comparative study between cytology and dot-ELISA for early detection of bladder cancer.
Attallah AM; el-Didi M; Seif F; el-Mohamady H; Dalbagni G
Am J Clin Pathol; 1996 Jan; 105(1):109-14. PubMed ID: 8561075
[TBL] [Abstract][Full Text] [Related]
2. Carcinoma of bilharzial bladder. Diagnostic value of urine cytology.
el-Bolkainy MN; Ghoneim MA; el-Morsey BA; Nasr SM
Urology; 1974 Mar; 3(3):319-23. PubMed ID: 4819693
[No Abstract] [Full Text] [Related]
3. A dipstick, dot-ELISA assay for the rapid and early detection of bladder cancer.
Attallah AM; Helmi H; el-Helali E; el-Mohamadi H
Cancer Detect Prev; 1991; 15(6):495-9. PubMed ID: 1723657
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin shedding in urine as a biological marker for bladder cancer: monoclonal antibody-based evaluation.
Helmy H; Seddek MN; Basta MT; Shaaban A; el-Baz M; el-Masry S; al-Hilaly ES; Ghoneim MA
Br J Urol; 1991 Sep; 68(3):248-53. PubMed ID: 1717095
[TBL] [Abstract][Full Text] [Related]
5. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
6. Cytokeratin shedding in urine: a biological marker for bladder cancer?
Basta MT; Attallah AM; Seddek MN; el-Mohamady H; Al-Hilaly ES; Atwaan N; Ghoneim M
Br J Urol; 1988 Feb; 61(2):116-21. PubMed ID: 2450613
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
8. A panel of angiogenic factors for early bladder cancer detection: enzyme immunoassay and Western blot.
Eissa S; Swellam M; Labib RA; El-Zayat T; El Ahmady O
J Urol; 2009 Mar; 181(3):1353-60. PubMed ID: 19185322
[TBL] [Abstract][Full Text] [Related]
9. Cytologic detection of bladder cancer in a rural Egyptian population infected with schistosomiasis.
El-Bolkainy MN; Chu EW; Ghoneim MA; Ibrahim AS
Acta Cytol; 1982; 26(3):303-10. PubMed ID: 6954812
[TBL] [Abstract][Full Text] [Related]
10. Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma.
Todenhöfer T; Hennenlotter J; Esser M; Mohrhardt S; Tews V; Aufderklamm S; Gakis G; Kuehs U; Stenzl A; Schwentner C
Cancer Cytopathol; 2013 May; 121(5):252-60. PubMed ID: 23172833
[TBL] [Abstract][Full Text] [Related]
11. The reliability of urinary cytology in the detection of tumours of urinary bladder.
Mondal A; Banerjee DK
J Indian Med Assoc; 1992 Oct; 90(10):265-7. PubMed ID: 1287085
[TBL] [Abstract][Full Text] [Related]
12. The clinical value of CYFRA21-1 in bladder cancer patients: Egyptian experience.
el-Ahmady O; Halim AB; el-Din AG
Anticancer Res; 1999; 19(4A):2603-8. PubMed ID: 10470202
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic value of urinary cytology in patients with bladder carcinoma.
Schoonees R; Gamarra MG; Moore RH; Murphy GP
J Urol; 1971 Nov; 106(5):693-6. PubMed ID: 5115726
[No Abstract] [Full Text] [Related]
14. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
[TBL] [Abstract][Full Text] [Related]
15. Schistosomiasis associated bladder carcinoma expression of cytokeratin.
Essa MH; Mangoud AM; Aly MA; el-Adl M; Morsy TA
J Egypt Soc Parasitol; 1990 Jun; 20(1):161-7. PubMed ID: 1692073
[TBL] [Abstract][Full Text] [Related]
16. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of cytology, nuclear matrix protein 22 (NMP22) test, and urinary bladder cancer II (UBC II) test in early recurrent transitional cell carcinoma of the bladder.
Kibar Y; Goktas S; Kilic S; Yaman H; Onguru O; Peker AF
Ann Clin Lab Sci; 2006; 36(1):31-8. PubMed ID: 16501234
[TBL] [Abstract][Full Text] [Related]
18. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.
Hautmann S; Toma M; Lorenzo Gomez MF; Friedrich MG; Jaekel T; Michl U; Schroeder GL; Huland H; Juenemann KP; Lokeshwar VB
Eur Urol; 2004 Oct; 46(4):466-71. PubMed ID: 15363562
[TBL] [Abstract][Full Text] [Related]
19. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.
Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ
J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813
[TBL] [Abstract][Full Text] [Related]
20. [Clinical value of combined detection with urinary bladder cancer antigen, hyaluronic acid and cytokeratin 20 in diagnosis of bladder cancer].
Pu XY; Wang ZP; Chen YR; Wu YL; Wang HP; Wang XH
Ai Zheng; 2008 Sep; 27(9):970-3. PubMed ID: 18799038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
